Related Experiment Video
Updated: Jul 3, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
[Neurohypophyseal neuropeptides and unipolar depression: which future?]
G Scantamburlo1, W Pitchot, M Ansseau
1Service de Psychiatrie et de Psychologie Médicale, Unité de Psychoneuroendocrinologie, CHU Sart Tilman, Liège, Belgique.
Abstract:
Vasopressin (AVP) and oxytocin (OT) are two chemically similar neurohypophyseal neuropeptides which could be involved in mood disorders. Those two sister neuropeptides might be considered as ago-antagonist hormones. They act as neuromodulators of the stress response. AVP is known as an ACTH stimulating factor synergistic to CRH while OT could act as an antagonist of AVP on ACTH secretion. AVP seems to play an important role in the pathophysiology of major depression. Evidence suggests a role for OT as an endogenous antidepressant/anxiolytic hormone. OT release is also an important aspect of the pharmacological action of SSRIs. In addition, their receptors are of growing interest for psychiatric research. A selective AVP V1b receptor, SSR1419415, has been characterized and is endowed with anxiolytic- an and antidepressant-like properties. This paper proposes an overview of neurohypophyseal hormones in major depression.
Related Concept Videos
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Neurotransmitters
